MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-WB-14-0028715
B2s Pharma Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹1.21 Cr
▲ 54% YoY
Net profit · FY 2022
₹34,798
Net margin 0.3%
EBITDA · FY 2022
₹56,913
EBITDA margin 0.5%
Authorised capital
₹11 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Open charges
₹9.99 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About B2s Pharma Private Limited
Data last updated:
B2s Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2016PTC209111. Its GSTIN is 19AAGCB5922P1Z4 (West Bengal).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Sharmila Saha and Sudipta Das.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Wireless Gate Purba Rabindra Pally Surya Sen Street P.O. Nonachandanpukur, Kolkata, West Bengal, India – 700122.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.21 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹34,798 (net margin 0.3%) and EBITDA of ₹56,913 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 33% over five years.
As per MCA filings, the company has open charges of ₹9.99 Lakh on record. Court records list 11 cases involving the company, including 11 filed against it; 7 cases are pending.
B2s Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-14-0028715). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website b2spharma.com.
Company details
CIN U74900WB2016PTC209111
Registration Number 209111
Incorporation Date 05 January 2016
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-14-0028715
Key People
Sharmila Saha Director Sudipta Das Director Recognitions & Rankings of B2s Pharma
Contact details
B2s Pharma Private Limited's registered office is in Kolkata, West Bengal. Its website is b2spharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressWireless Gate Purba Rabindra Pally Surya Sen Street P.O. Nonachandanpukur, Kolkata, West Bengal, India – 700122
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of B2s Pharma Private Limited, buy the company report.
Comprehensive company report
B2s Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of B2s Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of B2s Pharma Private Limited, buy the company report.
Financials of B2s Pharma Private Limited
FY 2022 filings availableB2s Pharma Private Limited reported revenue of ₹1.21 Cr (up 54% YoY) for FY 2022.
Revenue · FY 2022
₹1.21 Cr ▲ 54%
Net profit · FY 2022
₹34,798 margin 0.3%
EBITDA · FY 2022
₹56,913 margin 0.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 45%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 11%
5 years · compounded
▼ 15%
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 54% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.21 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56,913 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,798 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of B2s Pharma Private Limited, buy the company report.
Board of directors of B2s Pharma Private Limited
B2s Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharmila Saha | Director | 13 Oct 2022 | 4 Years 0 Months | Current |
| Sudipta Das | Director | 05 Jan 2016 | 10 Years 10 Months | Current |
Peer comparison
B2s Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Milus Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2024) | 228.0% | Mumbai, Maharashtra, India | |||
| Mandlive Healthcare Private Limited | ₹1.21 Cr (FY 2025) | 1.0% | Chandigarh, India | |||
| Rachit Remedies Private Limited | ₹1.21 Cr (FY 2025) | 0.0% | Patna, Bihar, India | |||
| B2s Pharma Private Limitedthis company | ₹1.21 Cr (FY 2022) | ₹34,798 | 0.3% | 54.0% | Kolkata, West Bengal, India | |
| Nordic Pharmaceuticals Limited | ₹1.21 Cr (FY 2025) | -10.0% | New Delhi, Delhi, India | |||
| Levitas Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2018) | 14.0% | Ernakulam, Kerala, India | |||
| Bindumadhav Pharma Private Limited | ₹1.2 Cr (FY 2024) | 40.0% | Panjim, Goa, India |
To see the full peer comparison of B2s Pharma Private Limited, buy the company report.
Auditor
B2s Pharma Private Limited is audited by BERIWAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BERIWAL & ASSOCIATES | FY 2021 | 327762E |
Shareholding
The shareholding of B2s Pharma Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of B2s Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.99 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2018 | 100199504 | State Bank of India | ₹9.99 Lakh | Open |
To see the full charge records of B2s Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
B2s Pharma Private Limited has 11 court cases on record: 11 filed against it. 7 cases are pending and 4 are disposed.
Total cases
11
Filed against the company
11
Pending
7
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 7 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company by Ikon Remedies Pvt Ltd Through Its Authorized Signatory Mr Riyaj Rahimtulla Sheikh | Pending |
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed against the company by Trireme Life Sciences Private Limited | Pending |
| District court, New Delhi, Delhi | Execution petition | Filed against the company by M/S Dr. Morepen Ltd. | Disposed |
| District court, New Delhi, Delhi | Civil suit | Filed against the company by M/S Dr. Morepen Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Aditya Birla Finance Limited | Disposed |
To see the full case history of B2s Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for B2s Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
B2s Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCB5922P1Z4 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of B2s Pharma Private Limited, buy the company report.
Recent activity
B2s Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Sharmila Saha was appointed as Director on 13 Oct 2022.
Appointed
Sharmila Saha was appointed as Director.
AGM
B2S Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Ceased
Chhandita Saha ceased to be Director.
Filing
B2S Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kolkata Ii.
Charges
A charge with State Bank Of India of Rs. 9.99 Lakh registered on 21 Aug 2018 with Charge ID 100199504 was modified on 15 Nov 2021.
Charges
A charge with State Bank Of India amounted to Rs. 9.99 Lakh with Charge ID 100199504 was registered on 21 Aug 2018.
Appointed
Sudipta Das was appointed as Director.
Incorporation
05 Jan 2016
B2S Pharma Private Limited was registered on 05 Jan 2016 with Roc Kolkata Ii & aged 10 years 10 months as per MCA records.
Frequently asked questions
B2s Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2016 (10+ years old) and is registered under CIN U74900WB2016PTC209111.
B2s Pharma has 2 current directors:
- Sharmila Saha - Director
- Sudipta Das - Director
The latest financial statements of B2s Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of B2s Pharma is 19AAGCB5922P1Z4, registered in West Bengal.
The CIN (Corporate Identification Number) of B2s Pharma is U74900WB2016PTC209111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
B2s Pharma has 11 court cases on record: 11 filed against it. 7 are pending.
B2s Pharma was incorporated on 05 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of B2s Pharma by revenue are Milus Pharmaceuticals Private Limited, Mandlive Healthcare Private Limited, Rachit Remedies Private Limited, Nordic Pharmaceuticals Limited, Levitas Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sharmila Saha was appointed as Director on 13 Oct 2022. Chhandita Saha ceased to be Director on 15 Sep 2022. Sudipta Das was appointed as Director on 05 Jan 2016.
Yes, B2s Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-14-0028715).
B2s Pharma can be reached through the website b2spharma.com. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages